TICKERNERD
Menu
PNTGPNTGHealthcare · Medical Care Facilities

PNTG Stock Forecast: The Pennant Group, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$41
+1.67% on the day

The 7 Wall Street analysts covering The Pennant Group, Inc. hold a median 12-month price target of $47 — +15.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 72 of 100 as at 14 Oct 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$1.4B
Ticker Nerd rank
72 / 100
Median analyst target
$47
Analysts covering
7
Revenue$298.0M+35.8% y/y
Operating income$17.2M
Net income$10.9M
Free cash flow$15.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+3.0%
1M
+1.8%
YTD
+45.0%
1Y
+69.6%
From 52W high
−3.9%
From 52W low
+72.7%
$24
$42
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PNTG stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Pennant Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
72 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
94
Momentum
93
Volatility
83
Growth
78
Quality
62
Value
43
Size
39
Accruals
27
Issuance
18

Revisions (94): Analysts have, on balance, been raising their forecasts.

Issuance (18): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PNTG stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PNTG, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$25$30$35$40$45$50Jan 26Apr 26Jul 26Oct 26PNTGHigh $49Median $47Low $44

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says7 analysts
7 Buy0 Hold0 Sell
Low $44Median $47High $49

The green dot is the last close — the median target sits +15.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
20 Aug 2026RBC CapitalMaintainsOutperform$42 → $44
11 Aug 2026Wells FargoMaintainsOverweight$45 → $46
14 July 2026Truist SecuritiesMaintainsBuy$42 → $48
14 July 2026Truist SecuritiesMaintainsBuy—
13 July 2026Wells FargoMaintainsOverweight$41 → $45
13 July 2026Wells FargoMaintainsOverweight—
8 May 2026RBC CapitalMaintainsOutperform—
8 May 2026Truist SecuritiesMaintainsBuy—
8 May 2026Wells FargoMaintainsOverweight—
13 Apr 2026Truist SecuritiesMaintainsBuy—
2 Mar 2026RBC CapitalMaintainsOutperform—
7 Jan 2026Wells FargoMaintainsOverweight—
8 Dec 2025William BlairInitiatesOutperform—
2 Dec 2025Truist SecuritiesUpgradeBuy—
18 Nov 2025Wells FargoUpgradeOverweight—
17 Nov 2025RBC CapitalMaintainsOutperform—
24 Oct 2025JefferiesInitiatesBuy—
9 Oct 2025Stephens & Co.ReiteratesOverweight—
4 Sept 2025Stephens & Co.ReiteratesOverweight—
14 Aug 2025Wells FargoMaintainsEqual-Weight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PNTG appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

PNTG vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, The Pennant Group, Inc. returned +69.6% against +17.5% for the S&P 500, dividends included.

PNTG vs S&P 500, last 12 monthsTotal return, rebased to 100
100120140160180Jan 26Apr 26Jul 26Oct 26PNTGS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PNTG analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.6%
Analysts raising
7
Analysts cutting
0
Fundamentals

The Pennant Group, Inc. (PNTG) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
44.1×

Cheaper than 17% of US stocks

Price / sales
1.3×

Cheaper than 63% of US stocks

Price / book
3.9×

Cheaper than 24% of US stocks

EV / EBITDA
25.9×

Cheaper than 10% of US stocks

Growth & margins
Revenue growth (YoY)
35.8%

Higher than 81% of US stocks

Earnings growth (YoY)
28.2%

Higher than 64% of US stocks

Gross margin
14.1%

Higher than 13% of US stocks

Operating margin
6.2%

Higher than 57% of US stocks

Net margin
2.9%

Higher than 55% of US stocks

Returns & dividend
Return on equity
10.4%

Higher than 64% of US stocks

Return on assets
4.5%

Higher than 74% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

The Pennant Group, Inc. (PNTG) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • The Pennant Group, Inc. has a market value of $1.4B and an enterprise value of $1.9B.

  • Revenue in the twelve months to 30 June 2026: $1.1B. The latest quarter grew 35.8% year on year.

  • Net income over the same four quarters: $38.5M, a 3.5% net margin.

  • Diluted earnings per share, trailing twelve months: $0.90.

  • Free cash flow in the twelve months to 30 June 2026: $34.7M.

  • Shares outstanding: 34.8M.

  • Trailing P/E: 44.1×; forward P/E: 25.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • The Pennant Group, Inc. employs 9,700 people — $114K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

PNTG vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
PNTGThe Pennant Group, Inc.$1.4B
72
AGLAgilon Health, Inc.$1.5B
70
NUTXNutex Health, Inc.$1.4B
88
AMNAMN Healthcare Services, Inc.$1.5B
100
HCSGHealthcare Services Group, Inc.$1.5B
95
USPHU.S. Physical Therapy, Inc.$1.3B
57
INNVInnovAge Holding Corp.$1.2B
98

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Pennant Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PNTG news & analysis

Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice

Zacks Investment Research · 21 Sept 2026positive

Zacks Investment Research evaluates whether The Pennant Group, Inc. qualifies as a top pick for momentum investors, highlighting the company as a great momentum choice in its screening analysis.

Why it matters — A Zacks momentum-focused assessment offers PNTG watchers an indication of how the stock's price and earnings trends are regarded by a prominent research firm.

The Pennant Group: The Pros Of Investing Continue To Outweigh The Cons

Seeking Alpha · 18 Sept 2026positive

A Seeking Alpha analysis maintains a Buy rating on The Pennant Group, citing robust fundamentals and strong stock appreciation since April 2023. The article highlights 36% revenue growth in 2025, guidance for 25% growth in 2026, and adjusted EPS and EBITDA ranges, underpinned by strategic acquisitions and operational excellence across home health, hospice, and senior living.

Why it matters — PNTG watchers would find this relevant as an independent analyst continues to endorse the company's growth trajectory and expansion strategy across its core service lines.

The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?

Zacks Investment Research · 17 Sept 2026neutral

The Pennant Group shares rose 6.3% last session on higher-than-average trading volume. The article notes that recent earnings estimate revision trends may not support the stock continuing higher in the near term.

Why it matters — PNTG watchers would care because the stock's recent gain may not be sustained given the current direction of earnings estimate revisions.

Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California

GlobeNewsWire · 16 Sept 2026positive

The Pennant Group acquired the real estate of Mainplace Senior Living, a senior living community in Orange, California, effective September 3, 2026. A Pennant affiliated subsidiary had operated the property under a triple-net lease since the company's 2019 spin-off.

Why it matters — This acquisition reflects Pennant's stated strategy of deploying capital to acquire senior living real estate at attractive pricing, converting an operated property into an owned asset that captures long-term real estate value.

All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy

Zacks Investment Research · 14 Sept 2026positive

Zacks Investment Research upgraded The Pennant Group (PNTG) to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. The rating change could drive the stock higher in the near term.

Why it matters — An upgrade to a Zacks Rank #2 (Buy) signals improved near-term earnings expectations, which PNTG watchers would view as a favorable development for the company's outlook.

FAQ

Frequently asked questions about PNTG stock

What is the PNTG stock price forecast for 2026-2027?

The 7 Wall Street analysts covering The Pennant Group, Inc. have a median 12-month price target of $47, with estimates ranging from $44 to $49. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PNTG stock a buy right now?

Of the 7 analysts covering The Pennant Group, Inc., 7 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Pennant Group, Inc. 72 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PNTG?

As at 14 Oct 2026, The Pennant Group, Inc. ranks 72 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (94 of 100).

Will PNTG stock go up?

No one can know that. What the data says: the median 12-month target from 7 analysts implies +15.1% from the last close, and Ticker Nerd's factor model ranks The Pennant Group, Inc. 72 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PNTG stock forecast for 2030?

No analyst covering The Pennant Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PNTG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $44 to $49 over the next 12 months.

How has PNTG stock performed over the past year?

The Pennant Group, Inc. returned +69.6% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Pennant Group, Inc. do?

The Pennant Group Inc is a healthcare services holding company focused on post-acute care in the United States. The Pennant Group Inc operates through two main segments: Home Health and Hospice Services, which provide skilled nursing, therapy, medical social work, home health aide support, and end-of-life care coordination, and Senior Living Services, which includes assisted living, independent living, and memory care communities.

What is the latest news on PNTG?

The most recent item we track (Zacks Investment Research, 21 Sept 2026): "Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice". Zacks Investment Research evaluates whether The Pennant Group, Inc. qualifies as a top pick for momentum investors, highlighting the company as a great momentum choice in its screening analysis.

Company

About The Pennant Group, Inc.

The Pennant Group Inc is a healthcare services holding company focused on post-acute care in the United States. The Pennant Group Inc operates through two main segments: Home Health and Hospice Services, which provide skilled nursing, therapy, medical social work, home health aide support, and end-of-life care coordination, and Senior Living Services, which includes assisted living, independent living, and memory care communities. Its business is centered on locally led care delivery for patients of all ages, with a particular emphasis on seniors and individuals recovering from illness or managing chronic conditions. Through its affiliated agencies and communities, The Pennant Group Inc plays a role in connecting clinical care, daily living support, and compassionate hospice services across multiple regional markets.

CEO Mr. Brent J. Guerisoli · 9,700 employees · United States · https://pennantgroup.com